NDC 13985-805 - CMPK
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-805
- Package NDCs from labels
- 13985-805-50
- Manufacturer
- MWI (VetOne)
- Effective date
- 2026-03-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CMPK - MWI (VetOne) | MWI (VetOne) | 2026-03-20 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-805-50 | CMPK | 500 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 500 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Calcium Gluconate Monohydrate | ACTIVE INGREDIENT | CZN0MI5R31 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Dextrose Monohydrate | ACTIVE INGREDIENT | LX22YL083G | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Magnesium Gluconate | ACTIVE INGREDIENT | T42NAD2KHC | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Potassium Chloride | ACTIVE INGREDIENT | 660YQ98I10 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Sodium Hypophosphite Monohydrate | ACTIVE INGREDIENT | 4VN69WUP7N | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Dextrose | ACTIVE MOIETY | IY9XDZ35W2 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Magnesium cation | ACTIVE MOIETY | T6V3LHY838 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Potassium cation | ACTIVE MOIETY | 295O53K152 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Genus Lifesciences | 14cd12ee-a4a3-465a-9550-58c9ef0e4f21 | 2025-07-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Schuessler Tissue Salts Kali Mur Glandular Tonic 5 | KALI MURIATICUM | Martin & Pleasance Pty Ltd | f4e2df47-0c8f-48c5-b6f3-2bd1e68afb89 | 2025-07-18 | Warnings | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3842a9c0-8b15-1c94-e063-6394a90ae120 | 2025-07-18 | Warnings, Adverse reactions | LX22YL083G |
| Calcium Gluconate | CALCIUM GLUCONATE | ProPharma Distribution | 38413366-b558-7dd0-e063-6394a90acb7e | 2025-07-18 | Warnings, Adverse reactions | CZN0MI5R31 |
| Potassium chloride | POTASSIUM CHLORIDE | Camber Pharmaceuticals, Inc. | fb2f6e74-4c1f-40c5-88a1-b88c069d4c75 | 2025-07-17 | Warnings, Adverse reactions | 660YQ98I10 |
| potassium chloride | POTASSIUM CHLORIDE | Solco Healthcare LLC | 52d91d76-8c7f-40f1-9f5c-e05962cabedd | 2025-07-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | 616f0de7-8843-44a1-8fa6-274d889286aa | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | 1ff53330-065c-4213-9c0c-ac498621d09d | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | e61a4522-b91d-400a-952c-6f035e4610dd | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| KLOR-CON M | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | b89910f6-4ff5-4a62-8269-696f7c10e4f6 | 2025-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE IN SODIUM CHLORIDE | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | ecc38772-246a-46c4-b42a-b9b81124f27f | 2025-07-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Upsher-SmithLaboratories, LLC | ad584ce4-a64d-4851-80e9-0eeedc0b9d06 | 2025-07-10 | Warnings, Adverse reactions | 660YQ98I10 |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 0956bd7c-d46f-483a-bf2c-9e11c6111ebf | 2025-07-02 | LX22YL083G | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b79ef556-37b3-4fd0-8589-c633033be9df | 2025-07-02 | LX22YL083G | |
| Schuessler Tissue Salts Kali Mur Glandular Tonic 5 | KALI MURIATICUM | Martin & Pleasance Pty Ltd | 4b2d8d03-c829-4292-ad94-993376d81b8f | 2025-07-01 | Warnings | 660YQ98I10 |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 36e9478c-5df0-4b47-b97d-de3626d7cb29 | 2025-06-30 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | American Health Packaging | b165ad93-1dc1-4863-9f0b-d7b97c42c94c | 2025-06-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride ER | POTASSIUM CHLORIDE ER | Direct_Rx | 377854ff-8034-c7ac-e063-6294a90a0817 | 2025-06-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Bio Electrolyte | BORON CITRATE, CALCIUM GLUCONATE, CHROMIUM PICOLINATE, COBALT GLUCONATE, COPPER GLUCONATE, MAGNESIUM GLUCONICUM DIHYDRICUM, MANGANESE GLUCONATE, NICKEL ACETATE, POTASSIUM GLUCONATE, SELENIUM DIOXIDE, SODIUM GLUCONATE, ZINCUM GLUCONICUM, FERRUM SULPHURICUM, KALI PHOSPHORICUM, VANADIUM METALLICUM, CALCAREA PHOSPHORICA | BioActive Nutritional, Inc. | 4482b868-4274-4fe7-8f5c-cf4eca3ecab8 | 2025-06-06 | Warnings | T42NAD2KHC |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.